Mar 22, 2007
By:
Marilyn Kochman
Patients receiving palliative care in hospices, hospitals, and other settings can benefit from a subcutaneous injection of morphine with Hylenex recombinant (hyaluronidase human injection).
|
|
BioPharm International's First Salary and Employee Satisfaction Survey
Jan 1, 2007
By:
Marilyn Kochman
The biotechnology industry is thriving, and hopefully you are too. BioPharm International's first salary and employee satisfaction survey presents a wealth of data that will allow you to compare many aspects of your job with those of your peers. The survey reports on demographics, education, work experience, salary and benefits, and attitudes toward current employment.
|
Oct 26, 2006
By:
Marilyn Kochman
The US Food and Drug Administration (FDA) issued a new guidance September 28 to help manufacturers develop safe and effective cell-based viral vaccines.
|
Sep 27, 2006
By:
Marilyn Kochman
Drugs developed by the fastest companies each gained an average of $1.1 billion in incremental prescription revenue and saved an average of $30 million in out-of-pocket development costs, compared to those of the slowest companies, according to Tufts University's Center for the Study of Drug Development (CSDD).
|
Aug 31, 2006
By:
Marilyn Kochman
Vaccines made with bacteria killed by gamma rays may be more effective than those made using standard heat or chemical inactivation, according to Sandip Datta, MD, assistant professor in the department of medicine, University of California, San Diego (http://www.ucsd.edu).
|
Jun 27, 2006
By:
Marilyn Kochman
The transdermal delivery of biologics-as well as of conventional drugs-is growing in popularity because the technique offers numerous advantages.
|
Jun 27, 2006
By:
Marilyn Kochman
On August 12, 2003, Johnson & Johnson began recalling certain batches of its anemia drug, Eprex (epoetin alfa, sold as Procrit in the US), in most countries outside of the United States.
|
|
